Clegend 洽购juno,juno盘后大漲超过42%![赞] Celgene
正威王文銀
2018-01-17 08:35:09
  • 点赞
  • 评论
  •   ♥  收藏
  • A
    分享到:
Clegend 洽购juno,juno盘后大漲超过42%![赞]
Celgene in talks to buy Juno Therapeutics: WSJ
Reuters Staff
(Reuters) - Celgene Corp (CELG.O) is in talks to buy Juno Therapeutics Inc (JUNO.O), which is working on an experimental gene therapy drug to treat cancer, the Wall Street Journal reported on Tuesday, citing sources familiar with the matter. (on.wsj.com/2EMlysO)
SPONSORED
Shares of Juno, which has a market value of $5.57 billion, were up 42 percent at $64.59 in extended trading.
Chimeric antigen receptor T-cell therapy, or CAR T, harnesses the ’s own immune cells to recognize and attack malignant cells. Novartis (NOVN.S) received the first U.S. Food and Drug Administration approval for a CAR T drug last year.
Juno does not yet have any FDA approvals for its CAR T drugs, but it released promising data from early trials for a blood cancer treatment in November.
It has had previous setbacks in developing the treatments, and shut down development of one leukemia treatment due to severe neurotoxicity that led to five patient deaths.
Still, CAR T treatments are expected to be blockbusters for drugmakers, costing up to $500,000 and generating billions of dollars in sales.
Celgene Corp
104.82
CELG.ONASDAQ
-1.18(-1.11%)
CELG.O
CELG.OJUNO.ONOVN.SGILD.O
Gilead Sciences Inc (GILD.O) bought Juno rival Kite Pharma Inc for nearly $12 billion late last year.
郑重声明:用户在财富号/股吧/博客等社区发表的所有信息(包括但不限于文字、视频、音频、数据及图表)仅代表个人观点,与本网站立场无关,不对您构成任何投资建议,据此操作风险自担。请勿相信代客理财、免费荐股和炒股培训等宣传内容,远离非法证券活动。请勿添加发言用户的手机号码、公众号、微博、微信及QQ等信息,谨防上当受骗!
信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-34289898 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:4000300059/952500